NCT05357469
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
Active, Not Recruiting
NAAges 18+InterventionalTreatmentM.D. Anderson Cancer CenterInvestigator-initiated
~30 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:Immediate St (Scrambler Therapy)Waitlist ST (Scrambler Therapy)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The European Organization for Research and Treatment of Cancer ( EORTC-QLQ C30)
Measured over through study completion, an average of 1 year
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Salahadin Abdi, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- The European Organization for Research and Treatment of Cancer ( EORTC-QLQ C30)through study completion, an average of 1 year
Five functional scales (physical, role, cognitive, emotional, and social); nine symptom scales (fatigue, pain, nausea and vomiting, dyspnea, loss of appetite, insomnia, constipation, diarrhea, and financial difficulties); and a global health status/QoL. Based on 30 questions in total, the scores range from 0 to 100.